Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Report: Mylan may have overcharged US by $1.3B for EpiPen
Report: Mylan may have overcharged US by $1.3B for EpiPen
Report: Mylan may have overcharged US by $1.3B for EpiPen
Submitted by
admin
on May 31, 2017 - 10:58pm
Source:
Drug Delivery Business News
News Tags:
Mylan Labs
EpiPens
Medicaid
Headline:
Report: Mylan may have overcharged US by $1.3B for EpiPen
Do Not Allow Advertisers to Use My Personal information
